Iressa

Iressa is a cancer medicine used to treat Non-small cell lung cancer (NSCLC) that has certain mutations in the EGFR gene. It helps block signals that cancer cells use to grow, slowing down or stopping the spread of the disease.

Benefits

• Slows the growth of lung cancer with EGFR mutations.
• Helps shrink tumors and relieve symptoms like coughing or breathing trouble.
• Taken orally — no need for injections or hospital infusions.
• Can improve quality of life and delay the need for chemotherapy.

Dosage

• The usual dose is 250 mg once a day.
• Take the tablet at the same time each day.
• Can be taken with or without food.
• Swallow the tablet whole with water — do not crush or chew.

Warnings and Precautions

• Not recommended if you don’t have an EGFR mutation — it may not work.
• Tell your doctor if you have lung, liver, or eye problems.
• May affect liver function — regular blood tests may be needed.
• Not safe during pregnancy or breastfeeding — use effective contraception.
• Can interact with other medications — always inform your doctor about what you’re taking.

Storage Information

• Store at room temperature (15°C to 30°C).
• Keep in a dry place, away from moisture and sunlight.
• Store in original packaging and out of reach of children.

Common Side Effects

• Mild to moderate effects: diarrhea, skin rash, dry skin, feeling weak or tired, loss of appetite, or sore mouth.
• Serious (seek medical attention): breathing problems, severe diarrhea, liver issues (such as yellowing of the skin or dark urine), or eye pain and vision changes.